799
We believe that this represents an unusual case of moderate-dose MTX-induced neurotoxicity in a patient with gastric cancer, which has not previously been reported.
 patient with gastric cancer: Subject; neurotoxicity: Effect; moderate-dose MTX: Treatment; gastric cancer: Treatment.Disorder; MTX: Treatment.Drug; moderate-dose: Treatment.Dosage
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 patient with gastric cancer: Subject; neurotoxicity: Effect; moderate-dose MTX: Treatment; gastric cancer: Treatment.Disorder; MTX: Treatment.Drug; moderate-dose: Treatment.Dosage